Brainscope

Findings suggest the potential of BrainScope technology
to aid in the triage of patients suspected of head injury in an acute setting

BETHESDA, MD., August 26,2010 - BrainScope Company, Inc. today announced the publication of clinical research findings from a study in patients presenting to the Emergency Department (ED) following a closed head injury. The study published in the peer-reviewed journal Brain Injury, the official journal of the International Brain Injury Association, entitled "Use of brain electrical activity to quantify traumatic brain injury in the emergency department", suggests BrainScope's technology, compared with Computed Tomography (CT), may provide clinically useful triage for CT in patients presenting to the ED.[...]

Study supports potential utility of BrainScope technology in development
for the assessment of traumatically induced brain injuries

BETHESDA, MD., July 13, 2010 – BrainScope Company, Inc. today announced the release of clinical research findings resulting from a 2008-2009 football concussion study of high school and college athletes it supported. The results, published in a special edition “Biomarkers in Mild Traumatic Brain Injury” of the peer-reviewed Journal of Head Trauma Rehabilitation, support the potential utility of the BrainScope device in development as a marker of recovery after sport-related concussion. [...]

Company Also Announces Formation of Medical Advisory Board

WASHINGTON, D.C., October 5th, 2009 – The BrainScope Company today announced that Gail Wilensky, Ph.D. has joined its Board of Directors and, separately, that it has also formed a Medical Advisory Board consisting of distinguished physicians from multiple fields applicable to BrainScope’s focus on developing products for assessment of Traumatic Brain Injury (TBI) (including mild TBI, also referred to as “Concussion”).

“Dr. Wilensky is one of the predominant health care thought leaders in the world today,” said BrainScope Chief Executive Officer Michael Singer. “Her extensive background serving in top leadership positions throughout the federal government and healthcare community will be a vital asset to us as BrainScope continues to develop a medical device that can provide reliable, rapid and objective assessment of Traumatic Brain Injury.” [...]

Technology Records and Displays Brain Activity at Initial Point of Care

WASHINGTON, D.C., August 11, 2009 – BrainScope Company Inc. today announced its first device, the ZOOM-100DC brain electrical activity data collection system, has been cleared for marketing by the U.S. Food and Drug Administration under section 510(k) of the FD&C Act. The ZOOM-100DC is an advanced 8-channel, portable, handheld electroencephalogram (EEG) device capable of recording and displaying EEG waveforms and providing conventional EEG measures displayed in tables.

The ZOOM-100DC is designed to be used at the initial point of care where traditional EEG tools are not readily available. The ZOOM-100DC is intended to monitor the state of the brain by acquisition and display of electroencephalogram (EEG) signals and by the calculation of standard quantitative EEG (qEEG) parameters. The ZOOM-100DC is a prescription use device. [...]

The Honorable James Peake, M.D. Joins BrainScope’s Board of Directors
Former Secretary of Veterans Affairs and
United States Army Surgeon General to Chair Company’s Medical Advisory Board

WASHINGTON, D.C.-May 04, 2009 – The BrainScope Company, Inc., the developer of medical devices with initial emphasis on brain injury assessment, today announced that retired Lieutenant General James Peake, M.D. [...]

BrainScope Positioned to Identify Traumatic Brain Injuries
Suffered by Military Troops
Companyʼs Hand-Held Brain Assessment Devices under Development Addresses
Congressional Call to Drive Accelerated Development of New Traumatic Brain Injury
Technologies

WASHINGTON–(BUSINESS WIRE)– March 23, 2009 –With awareness growing around the need for new ways to detect traumatic brain injuries, BrainScope Company Inc. today announced completion of data acquisition [...]

BrainScope Company, Inc. Announces
New Investment and Leadership to Fuel Growth
Revolution LLC, Alafi Capital and ZG Ventures to Provide New Investment
Revolution Founder Steve Case Joins BrainScope’s Board of Directors
Venture Capitalist Miles Gilburne Named Co-Chairman
Health and Technology Executive Michael Singer Named CEO
WASHINGTON–(BUSINESS WIRE)– Oct. 29, 2008 — BrainScope Company, Inc., developers of a new generation of non-invasive [...]